» Authors » Steven A Brown

Steven A Brown

Explore the profile of Steven A Brown including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 86
Citations 3202
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bernard C, Edmonds B, Kean K, Evans R, Bhamidipalli S, Tong Y, et al.
Contraception . 2025 Feb; :110833. PMID: 39892444
Objectives: To examine the association of social deprivation index (SDI) and contraception care in a statewide contraceptive access initiative (PATH4YOU) in Indiana. Study Design: A cross-sectional analysis was performed to...
2.
Richards R, Richards M, Musema J, Tackett A, Van Heiden S, Polsinelli A, et al.
Alzheimers Dement . 2024 Dec; 21(2):e14440. PMID: 39641412
More than 2 million older Americans from underrepresented racial and ethnic minority groups (URGs) have early-stage Alzheimer's disease and related dementias (ADRD). There are very few scalable recruitment strategies, particularly...
3.
Guerrero N, Ouyang F, Monahan P, Brown S, Zapolski T, Aalsma M
Public Health . 2024 Oct; 237:276-281. PMID: 39471699
Objectives: It is critical to understand supportive factors that may help mitigate the negative effects of racial discrimination on mental health. Supportive family environments positively impact adolescent health, yet less...
4.
Monroy A, Goodrich S, Brown S, Balanos T, Bakoyannis G, Diero L, et al.
AIDS Behav . 2024 Sep; 28(12):4020-4028. PMID: 39225889
We sought to investigate the association between hazardous alcohol use and gaps in care for people living with HIV over a long-term follow-up period. Adults who had participated in our...
5.
ElGrawani W, Mueller F, Schalbetter S, Brown S, Weber-Stadlbauer U, Tarokh L
Eur J Neurosci . 2024 Aug; 60(7):5505-5521. PMID: 39210746
Exposure to infectious or non-infectious immune activation during early development is a serious risk factor for long-term behavioural dysfunctions. Mouse models of maternal immune activation (MIA) have increasingly been used...
6.
Du N, Sinturel F, Nowak N, Gosselin P, Saini C, Guessous I, et al.
Eur J Neurosci . 2024 Aug; 60(7):5487-5504. PMID: 39205434
While it is generally known that metabolic disorders and circadian dysfunction are intertwined, how the two systems affect each other is not well understood, nor are the genetic factors that...
7.
ElGrawani W, Sun G, Kliem F, Sennhauser S, Pierre-Ferrer S, Rosi-Andersen A, et al.
Cell Rep . 2024 Jul; 43(7):114500. PMID: 39046880
Sleep debt accumulates during wakefulness, leading to increased slow wave activity (SWA) during sleep, an encephalographic marker for sleep need. The use-dependent demands of prior wakefulness increase sleep SWA locally....
8.
Tsai Y, ElGrawani W, Muheim C, Spinnler A, Campbell B, Lasic D, et al.
Eur J Neurosci . 2024 Jul; 60(7):5431-5449. PMID: 39032002
Sleep/wake cycles intricately shape physiological activities including cognitive brain functions, yet the precise molecular orchestrators of sleep remain elusive. Notably, the clinical impact of benzodiazepine drugs underscores the pivotal role...
9.
OReilly L, Schwartz K, Brown S, Dir A, Gillenwater L, Adams Z, et al.
Subst Abuse Treat Prev Policy . 2024 Jun; 19(1):32. PMID: 38907286
Background: Research demonstrates gaps in medications for opioid use disorder uptake (MOUDs; methadone, buprenorphine, and naltrexone) especially among adolescents. These gaps may be partly attributable to attitudes about and training...
10.
Dir A, OReilly L, Pederson C, Schwartz K, Brown S, Reda K, et al.
BMC Health Serv Res . 2024 May; 24(1):687. PMID: 38816829
Introduction: Rates of substance use are high among youth involved in the legal system (YILS); however, YILS are less likely to initiate and complete substance use treatment compared to their...